NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Medicines Update

MHRA Updates May & June 2017

Drug Safety Update (June 2017) includes:

 

 

Drug Safety Update (May 2017) includes:

 

Letters sent to healthcare professionals (May 2017):

 

Letters sent to healthcare professionals (April 2017):

  • In September 2016 we told you about the withdrawal of retigabine (Trobalt) from the market.
    In April 2017, a letter was sent reminding relevant healthcare professionals that all patients must be withdrawn from Trobalt by the end of June 2017.Withdrawal of a patient should be gradual and take place over at least 3 weeks, in accordance with the prescribing information.

Letters were also sent about the following medicines in April 2017: